CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex. This is the first FDA-cleared assay utilizing Roche's innovative TAGS (Temperature ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

In a recent study published in Nature Communications, researchers from the University of Chicago discovered that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) uses a small but ...

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) highlighted today the use of national anti-COVID-19 vaccines ...

A new study published in Clinical Infectious Diseases highlights the potential of pemivibart, a long-acting monoclonal ...

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...

Increased risk of long COVID seen with financial hardship, food insecurity, less than a college education, lack of social support.

Imunon has confirmed the deprioritization of its COVID-19 vaccine program. With the company’s cash reserves falling below $5 ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

The public discourse around the origin of the pandemic has increasingly been shaped by political agendas and conspiratorial ...